Abstract
Retrovirus-derived vectors are overwhelmingly preferred over other methods for ex vivo gene therapy because they provide permanent integration of foreign genes into cellular DNA. In comparison, cationic lipids mediate efficent gene transfer, but expression is transient. When we combined cationic lipids with retrovirus particles we obtained a significant enhancement of transduction efficiency, depending upon the type of lipid formulation and the dose used. The relative effectiveness of these cytofectins was: DOSPA:DOPE>DOTMA:DOPE>DOTAP, resulting in 60-, 37-, and 5-fold increases in transduction efficiency, respectively, at optimum dosage. The effect of polycationic DOSPA:DOPE was dependent upon the viral envelope glycoprotein, was attainable by lipid treatment of either cells or virus particles, was not enhanced by the addition of polybrene, and was inhibited by chloroquine. These results strongly suggested that DOSPA:DOPE act primarily by modulation of charge associated with the viral envelope and cell membrane, enhancing retroviral transduction, rather than by providing an alternative pathway of transfection. DOSPA:DOPE is useful for improving the efficiency of gene transfer as well as the sensitivity with which retroviruses can be detected in biological fluids.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hodgson, C.P., 1995. The vector void in gene therapy. Bio/Technology 13: 222–225.
Curiel, D.T., Agarwal, S. and Wagner, E. and Cotten, M. 1991. Adenovirus enhancement of transferrin-mediated gene delivery. Proc. Natl. Acad. Sci. USA 88: 8850–8854.
Curiel, D.T., Wagner, E., Cotten, M., Birnstiel, M.L., Agarwal, S., Li, C., Loechel, S. and Hu, P. 1992. High efficiency in vitro gene transfer mediated by adenovirus coupled to DNA-polylysine complexes via an antibody bridge. Hum. Gene Ther. 3: 147–154.
Kasahara, N., Dozy, A.M. and Kan, Y.W. 1994. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 226: 1373–1375.
Jolly, D. and Barber, J. 1992. Helper cells. World Intellectual Property Organization (WIPO) patent publication WO92/05266.
Wu, G.Y. and Wu, C.H. 1992. Targeting viruses and cells for selective internalization by cells. World Intellectual Property Organization (WIPO) patent publication WO92/06180.
Yee, J.-K., Mkyanohara, A., LaPorte, P., Bouic, K., Burns, J.C. and Friedman, T. 1994. A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA 91: 9564–9568.
Debs, R.J. and Zhu, N. 1993. In vivo gene therapy with intron-free sequence of interest. World Intellectual Property Organization (WIPO) Publication WO93/25673.
Wilson, T., Papahadjopoulos, D. and Taber, R. 1977. Biological properties of poliovirus encapsulated in lipid vesicles: Antibody resistance and infectivity in virus-resistant cells. Proc. Natl. Acad. Sci. USA 74: 3471–3475.
Faller, D.V. and Baltimore, D. 1984. Liposome encapsulation of retrovirus allows efficient superinfection of resistant cell lines. J. Virol. 49: 269–272.
Lasic, D.D. and Papahadjopoulos, D. 1995. Liposomes revisited. Science 267: 1275–1276.
Kondorosi, E. and Duda, E. 1982. Infection of cells with Sindbis virus nucleocapsids entrapped into liposomes. Biochem. Biophys. Res. Commun. 107: 367–373.
Wilson, T., Papahadjopoulos, D. and Taber, R. 1977. Biological properties of poliovirus encapsulated in lipid vesicles: antibody resistance and infectivity in virus-resistant cells. Proc. Natl. Acad. Sci. USA 74: 3471–75.
Konopka, K., Davis, B.R., Larsen, C.E., Alford, D.R., Debs, R.J. and Duzgunes, J. 1990. Liposomes modulate human immunodeficiency virus infectivity. J. Gen. Virol. 71: 2899–2907.
Innes, C.L., Smith, B., Langenback, R., Tindall, K.R. and Boone, L.R. 1990. Cationic liposomes (Lipofectin) mediate retroviral infection in the absence of specific receptors. J. Virol. 64: 957–961.
Feigner, J.H., Kumar, R., Sridhar, C.N., Wheeler, C.J., Tsai, Y.J., Border, R., Ramsey, P., Martin, M. and Feigner, P.L. 1994. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269: 2550–2561.
Price, J., Turner, D. and Cepko, C. 1987. Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 84: 156–160.
Miller, A.D. and Buttimore, C. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6: 2895–2902.
Markowitz, D., Goff, S. and Bank, A. 1988. A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 62: 1120–1124.
Chakraborty, A.K., Zink, M.A. and Hodgson, C.P. 1995. Expression of VL30 vectors in human cells that are targets for gene therapy. Biochem. Biophys. Res. Commun. 209: 677–683.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hodgson, C., Solaiman, F. Virosomes: Cationic Liposomes Enhance Retroviral Transduction. Nat Biotechnol 14, 339–342 (1996). https://doi.org/10.1038/nbt0396-339
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0396-339
This article is cited by
-
Cryo-EM structure and polymorphic maturation of a viral transduction enhancing amyloid fibril
Nature Communications (2023)
-
Vectofusin-1, a New Viral Entry Enhancer, Strongly Promotes Lentiviral Transduction of Human Hematopoietic Stem Cells
Molecular Therapy - Nucleic Acids (2013)
-
Optimization of the Transductional Efficiency of Lentiviral Vectors: Effect of Sera and Polycations
Molecular Biotechnology (2013)
-
Efficient Enhancement of Lentiviral Transduction Efficiency in Murine Spermatogonial Stem Cells
Molecules and Cells (2012)
-
Redirecting adenovirus to pulmonary endothelium by cationic liposomes
Gene Therapy (2002)